From: Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study
Patient
Viso115% (cm3)
DSC BTV-Viso115% (%)
Plan 1
Plan 2-SIB
1
14
18.6
0.26
0.45
2
22.2
12
0.21
0.4
3
10
11.6
0.51
Mean (± SD)
15.4 ± 6.2
14.1 ± 3.9
0.31 ± 0.13
0.45 ± 0.06